This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Buyout Bid Lifts Osteotech

The Musculoskeletal Transplant Foundation, an organization that deals with bone, ligament and cartilage transplantation, said it has offered to buy Osteotech (OSTE) at a premium to its last close, but the company rejected the bid.

The foundation said it sent a letter to Osteotech's board on July 12 proposing to buy the company for $6.25 a share in cash. On Aug. 19, Osteotech said its board had rejected the proposal, according to the foundation. In a press release Monday, the foundation said it remained interested in acquiring Osteotech.

Osteotech, based in Eatontown, N.J., provides human bone and bone connective tissue for transplantation. After news of the takeover offer became known, shares of Osteotech jumped $1.16, or 26%, to $5.62. The stock has a 52-week range of $2.45 to $5.83.

"At the core of our charitable mission is an obligation to donor families and tissue recipients to make the best use we possibly can of these precious donated tissues and to do so in the most cost-effective manner," the foundation said. "However, our ability to accomplish this is severely compromised by our current relationship with Osteotech. Therefore, we believe we can better fulfill our mission by merging the Osteotech and MTF operations."

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs